Company Overview and News
American Water Works (AWK - Free Report) announced that its unit New Jersey American Water has entered into an agreement to acquire Roxbury Water Company, which is based in Morris County, NJ. This acquisition is subject to approval from the New Jersey Board of Public Utilities and will increase the customer base of New Jersey American Water by 3,900. New Jersey American Water already provides services to 623,000 water customers as well as 34,000 wastewater customers in New Jersey and operates 8,900 miles of pipeline (water and wastewater) in the state.
CTWSP CTWSO ES WTR CTWS
NextEra Energy, Inc. (NEE - Free Report) is expected to beat earnings when it reports second-quarter 2018 results, which is slated to be announced on July 25 before the opening bell. Last quarter, this utility reported a positive earnings surprise of 8.99%. Why a Likely Positive Surprise? Our proven model shows that NextEra Energy is likely to beat on earnings because it has the right combination of two key ingredients.
NEE.PRI NEE.PRJ AEP.PRA ES KDP NEE.PRC NEE.PRQ AEP NEE.PRR NEE
American Water Works Company (AWK - Free Report) announced that its subsidiary, New Jersey American Water has decided to invest $3 million for strengthening its 13,000-foot water main located in Garwood, NJ. The cleaning and lining process is already underway, which will remove sediment from inside the water main and then the inner surface of the main will be lined with a cement sealant. New Jersey American Water has been consistently working to improve the quality of water and reliability of its services.
ES GEC GE WTR GNE
July 13 (Reuters) - Connecticut Water Service Inc rejected a revised takeover offer from Eversource Energy, according to regulatory filings from both companies on Friday, insisting it would consider abandoning its planned merger with another utility only for a much higher offer.
CTWSP CTWSO ES CTWS CWT
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Biogen (BIIB) and General Motors (GM). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
AMP ES BIIB JNJ GM.WS.A GM.WS.B KHC GM.WS.C GM VLO GM.WSB
Eversource Energy (ES - Free Report) has reaffirmed its original offer to acquire Connecticut Water Service, Inc. at $63.50 per share in cash or Eversource shares. Eversource’s earlier offer was rejected by management of Connecticut Water Service, citing that it was inferior to the offer made by SJW Group (SJW - Free Report) . (Read more: :Connecticut Water Loyal to SJW Group, Rejects Eversource Bid)
CTWSP CTWSO ES CTWS CSX MGYTF
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to ES / Eversource Energy on message board site Silicon Investor.
as of ET